Literature DB >> 22430445

Decline in infantile hypertrophic pyloric stenosis in Germany in 2000-2008.

Jan de Laffolie1, Salmai Turial, Matthias Heckmann, Klaus-Peter Zimmer, Felix Schier.   

Abstract

BACKGROUND AND
OBJECTIVE: The incidence of infantile hypertrophic pyloric stenosis (IHPS) is highly variable over time and geographic regions. A decline in IHPS incidence was recently reported in Sweden, the United States, Denmark, and Scotland. In Sweden, the IHPS decline seemed to be concurrent with a declining incidence in sudden infant death syndrome (SIDS), which suggested a common cause; the latter was attributed to campaigns against the prone sleeping position. We investigated the time course of the IHPS incidence in all German federal states (N = 16) between 2000 and 2008. We examined correlations between the IHPS incidence and the SIDS incidence.
METHODS: Data were extracted from the public report of health (Gesundheitsberichterstattung des Bundes). We collected the numbers of IHPS (International Classification of Diseases, 10th Revision [ICD-10], code 40.0), SIDS (ICD-10, R95), and live births (LB; male/female) in each federal state for 2000-2008.
RESULTS: The IHPS incidence declined in Germany from 2000 (3.2086/1000 LB [range: 1.67-5.33]) to 2008 (2.0175/1000 LB [1.74-3.72]; P = .005). The recorded incidence was highly variable in different federal states and over time. The SIDS incidence also declined during the same time period (2000, median: 0.759/1000 LB [interquartile range: 0.54-1.029]; 2008, median: 0.416/1000 LB [interquartile range: 0.285-0.6485]; P = .0255). However, the SIDS regional distribution was different from that of IHPS.
CONCLUSIONS: The IHPS incidence declined by ∼38% nationwide. A parallel decline in SIDS displayed a different pattern in regional distribution; thus, a common cause was unlikely. The regional differences indicated that etiologic factors remained unresolved.

Entities:  

Mesh:

Year:  2012        PMID: 22430445     DOI: 10.1542/peds.2011-2845

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Prenatally buprenorphine-exposed children: health to 3 years of age.

Authors:  Kaisa Kivistö; Sarimari Tupola; Satu Kivitie-Kallio
Journal:  Eur J Pediatr       Date:  2015-05-24       Impact factor: 3.183

2.  Similarities and differences in the epidemiology of pyloric stenosis and SIDS.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Matern Child Health J       Date:  2014-09

3.  A novel missense mutation in the transcription factor FOXF1 cosegregating with infantile hypertrophic pyloric stenosis in the extended pedigree linked to IHPS5 on chromosome 16q24.

Authors:  Kate V Everett; Paris Ataliotis; Barry A Chioza; Charles Shaw-Smith; Eddie M K Chung
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

4.  Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.

Authors:  Renuka Kapoor; Vijaya Kancherla; Yanyan Cao; Jacob Oleson; Jonathan Suhl; Mark A Canfield; Charlotte M Druschel; Russell S Kirby; Robert E Meyer; Paul A Romitti
Journal:  Birth Defects Res       Date:  2018-12-13       Impact factor: 2.344

5.  Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.

Authors:  Marie Lund; Björn Pasternak; Rie B Davidsen; Bjarke Feenstra; Camilla Krogh; Lars J Diaz; Jan Wohlfahrt; Mads Melbye
Journal:  BMJ       Date:  2014-03-11

6.  The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  Hamdi H Almaramhy; Abdulmohsen H Al-Zalabani
Journal:  Ital J Pediatr       Date:  2019-02-04       Impact factor: 2.638

7.  Open versus laparoscopic pyloromyotomy for pyloric stenosis.

Authors:  Ralph F Staerkle; Fabian Lunger; Lukas Fink; Tom Sasse; Martin Lacher; Erik von Elm; Ahmed I Marwan; Stefan Holland-Cunz; Raphael Nicolas Vuille-Dit-Bille
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09

Review 8.  Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  L Murchison; P De Coppi; S Eaton
Journal:  Pediatr Surg Int       Date:  2016-09-21       Impact factor: 1.827

9.  Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis.

Authors:  Bjarke Feenstra; Frank Geller; Lisbeth Carstensen; Paul A Romitti; Izabella Baranowska Körberg; Bruce Bedell; Camilla Krogh; Ruzong Fan; Anna Svenningsson; Michele Caggana; Agneta Nordenskjöld; James L Mills; Jeffrey C Murray; Mads Melbye
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

10.  Hypertrophic Pyloric Stenosis: 10 Years' Experience with Standard Open and Laparoscopic Approach.

Authors:  Nicola Zampieri; Valentina Corato; Gabriella Scirè; Francesco Saverio Camoglio
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.